Study of antioxidant potential of malotilate in ethanol induced hepatic dysfunction in Sprague Dawley rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20160749Keywords:
ALD, Malotilate, Sprague Dawley Rats, MDA, SOD, CAT, HistopathologyAbstract
Background: Alcoholic liver disease (ALD) is one of the major causes of mortality and morbidity worldwide. Objective of the study was to elicit a preventive mechanism of malotilate, a reported potent hepatoprotective agent, against ethanol induced sub-acute hepatotoxicity. Both ethanol and malotilate were administered for 21 days to evaluate the toxicity and prevention by the drug molecule.
Methods: Thirty adult healthy Sprague Dawley rats of either sex, weighing 200-250 g selected for the study, were randomly divided into 5 groups; treated with ethanol, ethanol with vehicle carboxy methyl cellulose for malotilate solution and three different doses of malotilate having six rats in each group. All the treatments were given once a day for 21 days. On 22nd day, rats were sacrificed by cervical dislocation and dissected for collection of liver. The dissected livers were divided into two parts. One part was homogenized to assess oxidative stress marker enzymes malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) spectrophotometrically and second parts of the liver were processed for histopathological assessment i.e. histopathological scores (HPS) of liver damage.
Results: Malotilate (100, 50 and 25 mg/kg) significantly reduced MDA levels and increased SOD as well as CAT levels when compared with only ethanol treated group and ethanol with vehicle for drug solution treated groups suggested antioxidant activity. The malotilate treatment groups scored the lowest HPS suggested remarkable liver protection from alcohol induced injury.
Conclusions: The overall results, suggested the significant liver protection offered by malotilate by reducing oxidative stress in a dose-dependent manner. The histopathological scoring evidenced the prevention of hepatotoxicity by malotilate, which showed significant activity in 21 days of treatment. Future studies may be focussed on the molecular mechanism of the drug and its curative property as hepatoprotective action.
References
Zhang J, Gao Y, Qian S, Liu X, Zu H. Physicochemical and pharmacokinetic characterization of a spray-dried malotilate emulsion. Int J Pharm. 2011;414(1-2):186-92.
Younes M, Siegers CP. Effect of Malotilate on paracetomol induced hepatotoxicity. Toxicol Lett. 1985;25(2):143-6.
Borole KD, Bodhankar SL. Preventive effect of malotilate on ethanol induced hepatic dysfunction in rats. Int J Pharm Bio Sci. 2014;5(1):151-7.
Nand N, Malhotra P, Dhoot DK. Clinical Profile of Alcoholic Liver Disease in a Tertiary Care Centre and its Correlation with Type, Amount and Duration of Alcohol Consumption. J Assoc Physicians India. 2015;63(6):14-20.
Alcohol consumption rising fast in India: OECD report. http://indianexpress.com/article/india/india-others/alcohol-consumption-rising-fast-in-india-oecd-report/#sthash.HAfHXtwD.dpuf. Accessed on 26 February 2016.
WHO Global Status Report on alcohol and health, 2014. http://www.who.int/substance_abuse/ publications/global_alcohol_report/en. Accessed on 26 February 2016.
Rasineni K, Casey CA. Molecular mechanism of alcoholic fatty liver. Indian J Pharmacol. 2012;44(3):299-303.
Corrao G, Torchio P, Zambon A, D’Amicis A, Lepore AR, di Orio F. Alcohol consumption and micronutrient intake as risk factors for liver cirrhosis: a case control study. Ann Epidemiol. 1998;8(3):154.
D Dahiru1 and O Obidoa. Pretreatment of albino rats with aqueous leaf extract of Ziziphus mauritiana protects against alcohol-linduced liver damage Tropical Journal of Pharmaceutical Research. 2007;6(2):705-10.
Mark E. Cleasby, Nicolas Dzamko, Bronwyn D. Hegarty, Gregory J. Cooney, Edward W. Kraegen, and Ji-Ming Ye. Metformin Prevents the Development of Acute Lipid-Induced Insulin Resistance in the Rat Through Altered Hepatic Signaling Mechanisms. Diabetes 2004;53:3258-66.
Angela C. Smith, Kerry L. Mullen,1 Kathryn A. Junkin, Jennifer Nickerson, Adrian Chabowski, Arend Bonen, and David J. Dyck. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am J Physiol Endocrinol Metab. 2007;293:E172-81.
Aliahmat NS, Noor MRM, Yusof WJW, Makpol S, Ngah WZW, Yusof YAM. Antioxidant enzyme activity and malondialdehyde levels can be modulated by Piper betle, tocotrienol rich fraction and Chlorella vulgaris in aging C57BL/6 mice. Clinics (Sao Paulo). 2012;67(12):1447-54.
Yayalacı Y, Celik I, Batı B. Hepatoprotective and antioxidant activity of linden (Tilia platyphyllos L.) infusion against ethanol-induced oxidative stress in rats. J Membr Biol. 2014;247(2):181-8.
Li S, Tan H-Y, Wang N, Zhang Z-J, Lao L, Wong C-W, et al. The Role of Oxidative Stress and Antioxidants in Liver Diseases. Int J Mol Sci. 2015;16:26087-124.
Takahashi Y, Fukusato T. Histopathology of nonalcoholic fatty liver disease/non-alcoholic steatohepatitis. World J Gastroenterol. 2014;20(42):15539-48.
